NCT00268307View on ClinicalTrials.gov

Bone Marrow Stem Cell Infusion Following a Heart Attack

PHASE1CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

January 31, 2010

Study Completion Date

September 30, 2010

Conditions
Acute Myocardial Infarction
Interventions
DRUG

Autologous, Unfractionated Bone Marrow Mononuclear Cells

Intracoronary infusion of Autologous, Unfractionated Bone Marrow Mononuclear Cells. Dose is 100,000,000 cells. One time infusion over 20 minutes.

Trial Locations (1)

55407

Minneapolis Heart Institute Foundation, Minneapolis

All Listed Sponsors
collaborator

Allina Health System

OTHER

lead

Minneapolis Heart Institute Foundation

OTHER

NCT00268307 - Bone Marrow Stem Cell Infusion Following a Heart Attack | Biotech Hunter | Biotech Hunter